Do you like AMG 151 because it is a GKA? I'd be interested to know what specifically you like about it? Only early P1 data is public as far as I know and you seem to be skeptical about early data. Lilly terminated a GKA trial a while back for what appears to be safety reasons.
Market Data 
Markets 
AI
